TransCode Therapeutics Inc (RNAZ)
0.8502
+0.03
(+3.68%)
USD |
NASDAQ |
May 06, 09:58
TransCode Therapeutics 1 Year Total Returns (Daily): -99.66% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -99.66% |
May 02, 2024 | -99.73% |
May 01, 2024 | -99.76% |
April 30, 2024 | -99.76% |
April 29, 2024 | -99.77% |
April 26, 2024 | -99.81% |
April 25, 2024 | -99.82% |
April 24, 2024 | -99.83% |
April 23, 2024 | -99.84% |
April 22, 2024 | -99.84% |
April 19, 2024 | -99.83% |
April 18, 2024 | -99.84% |
April 17, 2024 | -99.84% |
April 16, 2024 | -99.84% |
April 15, 2024 | -99.83% |
April 12, 2024 | -99.80% |
April 11, 2024 | -99.80% |
April 10, 2024 | -99.79% |
April 09, 2024 | -99.78% |
April 08, 2024 | -99.78% |
April 05, 2024 | -99.82% |
April 04, 2024 | -99.74% |
April 03, 2024 | -99.77% |
April 02, 2024 | -99.75% |
April 01, 2024 | -99.74% |
Date | Value |
---|---|
March 28, 2024 | -99.73% |
March 27, 2024 | -99.73% |
March 26, 2024 | -99.74% |
March 25, 2024 | -99.73% |
March 22, 2024 | -99.75% |
March 21, 2024 | -99.75% |
March 20, 2024 | -99.74% |
March 19, 2024 | -99.73% |
March 18, 2024 | -99.74% |
March 15, 2024 | -99.75% |
March 14, 2024 | -99.77% |
March 13, 2024 | -99.78% |
March 12, 2024 | -99.81% |
March 11, 2024 | -99.80% |
March 08, 2024 | -99.80% |
March 07, 2024 | -99.79% |
March 06, 2024 | -99.81% |
March 05, 2024 | -99.81% |
March 04, 2024 | -99.81% |
March 01, 2024 | -99.82% |
February 29, 2024 | -99.83% |
February 28, 2024 | -99.83% |
February 27, 2024 | -99.81% |
February 26, 2024 | -99.79% |
February 23, 2024 | -99.81% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.90%
Minimum
Feb 01 2024
-48.10%
Maximum
Jul 20 2022
-85.40%
Average
-89.06%
Median
1 Year Total Returns (Daily) Benchmarks
Citius Pharmaceuticals Inc | -52.68% |
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |